PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
06-Feb-2020 Vynamic opens 4th office in Durham, North Carolina to meet new and existing client demand in the region Vynamic
06-Feb-2020 Pharmapack Europe 2020 Award Winners Announced Pharmapack
04-Feb-2020 Urinalysis Market Outlook to 2026: Top Companies, Trends & Growth Factors Details for Business Development Reports And Data
04-Feb-2020 Cellulite Reduction Devices Market Share, Growth, Trends, Global Scope and 2026 Forecast Orian Research
04-Feb-2020 Global Pressure Relief Devices Market Outlook 2019-2026: Stryker Corp., Smith & Nephew, Invacare Corporation Reports And Data
04-Feb-2020 Pharmacovigilance Market Outlook 2019-2026: Accenture, Clinquest Group B.V., Cognizant Reports And Data
04-Feb-2020 Multiple Sclerosis Therapeutics Market Outlook to 2026: Top Companies Reports And Data
03-Feb-2020 Envision Pharma Group kick off 2020 by scooping a triple win at the PM Society Awards Envision Pharma Group
31-Jan-2020 Ashfield’s medical writing programme Allegro hits 100 milestone Ashfield Healthcare Communications
31-Jan-2020 Clinerion and Datametrix partner to deliver Real World Evidence (RWE) insights from Real World Data (RWD) from Clinerion’s global hospital network. Clinerion Ltd
31-Jan-2020 Reich Insurance launches innovative online Life Sciences insurance quote portal Reich Insurance Group
30-Jan-2020 Cynbiose receives €1.9 million ($2.1M) to launch CYNBIOME, preclinical excellence network on microbiome and infectious diseases Cynbiose
30-Jan-2020 European Medicines Agency Validates Kite's Marketing Authorisation Application for Company's Second CAR T Cell Therapy Kite
30-Jan-2020 Abcam Expands Cell Engineering Capabilities Through Asset Purchase of Applied StemCell’s Gene Editing Platform and Oncology Product Portfolio ABCAM PLC
30-Jan-2020 REGULATORY ANNOUNCEMENT: Astellas Submits sNDA for Approval of Evrenzo® (roxadustat) Astellas Pharma Inc.
30-Jan-2020 Sanofi: Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency Sanofi
30-Jan-2020 FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis Sanofi
30-Jan-2020 Agilent Introduces New Cutting-Edge SureSelect DNA Kit Agilent Technologies Inc.
30-Jan-2020 NuCana Announces First Patients Dosed in Both US and Europe in Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer NuCana plc
30-Jan-2020 Akari Therapeutics Announces Preclinical Ophthalmic Data Showing Nomacopan Reduces Both Vascular Endothelial Growth Factor (VEGF) and Retinal Inflammation Supporting Nomacopan as a Potential Treatment Option for Back-of-the-Eye Diseases Akari Therapeutics